● Completed

Single Ascending Doses Study of KLS-2031 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy

Condition: Neuropathic Pain From Lumbosacral Radiculopathy · Sponsor: Kolon Life Science

PhasePhase 1/Phase 2

Planned participants18

Who can joinAll sexes, 18 Years to 75 Years

Healthy volunteersNo

About this study

Escalating single-dose design study to determine the safety, tolerability, and analgesic activity of KLS-2031

This description comes directly from the study's public registry record.

Talk to the study team

Contact details are listed per location below or on the registry record.

Always discuss trial participation with your own doctor first.

Locations (1)

Kolon Investigative Site : CenExel JBR

Salt Lake City, Utah, United States

—

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04238793